BECN1 and glioblastoma: Simultaneous application of LY294002 and sorafenib in anaplastic astrocytoma, as well as in glioblastoma multiforme, affected the co-localization of Bcl-2 and beclin-1, which were distributed around the formed apoptotic bodies.